Vitamin D Screening and Supplementation in Primary Care: Time to Curb Our Enthusiasm
Am Fam Physician. 2018 Feb 15;97(4):226-227.
Recent trends in vitamin D testing and supplementation strongly suggest that physicians and patients believe that identifying and correcting vitamin D deficiency improves health outcomes. From 2000 to 2010, the volume of serum 25-hydroxyvitamin D (25-OH-D) tests reimbursed by Medicare Part B increased 83-fold.1 In 2000, four out of 1,000 U.S. adults 70 years or older reported taking a daily vitamin D supplement of at least 1,000 IU, compared with four out of 10 in 2014—a 100-fold increase.2
In contrast, LeFevre and LeFevre's review of the evidence for vitamin D screening and supplementation in adults in this issue of American Family Physician determined that these commonplace practices have virtually no established health benefits.3 The American Society for Clinical Pathology recommends against screening for vitamin D deficiency in the general population.4 The U.S. Preventive Services Task Force found insufficient evidence that vitamin D supplementation prevents cardiovascular disease, cancer, or fractures in community-dwelling adults.5–7 An umbrella review of more than 100 systematic reviews and meta-analyses of observational studies and randomized controlled trials found only a handful of “probable” relationships between serum vitamin D concentrations and clinical outcomes, and concluded that vitamin D supplementation does not increase bone mineral density or reduce the risk of fractures or falls in older adults.8
What factors explain the disconnect between the research on vitamin D and the great enthusiasm for screening and supplementation in clinical practice? First, vitamin D is a vitamin—by definition, something the body needs. To many adults, a relationship between vitamin D levels and general health seems plausible because they spend most of their time indoors and are counseled by clinicians to minimize sun exposure to reduce skin cancer risk.9 Second, earlier research had suggested positive effects that were not subsequently borne out. For example, observational studies often make news by publicizing associations between low vitamin D levels and chronic conditions such as cardiovascular disease,8 but subsequent randomized controlled trials showing negative results may be less widely reported.10 Clinicians may misapply evidence that vitamin D supplements reduce fall rates in institutionalized older adults11 to community-dwelling populations. Finally, physicians may misinterpret serum 25-OH-D concentrations of 20 to 30 ng per mL (50 to 75 nmol per L) as representing a deficiency that requires correction, when the National Academy of Medicine (formerly the Institute of Medicine) considers 97.5% of individuals with levels greater than 20 ng per mL to have adequate vitamin D for bone health.12
Screening for vitamin D deficiency leads to hundreds of millions of dollars wasted in testing costs annually.3 Low-level daily supplementation with calcium and vitamin D can increase the risk of kidney stones,13 and higher monthly doses of vitamin D increased the risk of falls in a randomized controlled trial of older adults with vitamin D deficiency.14 The National Academy of Medicine has noted that vitamin D intakes above the tolerable upper limit of 4,000 IU per day may cause toxic effects such as renal impairment, hypercalcemia, or vascular calcification.15 In 2014, 3% of all U.S. adults and 6.6% of adults older than 60 years reported taking a vitamin D supplement of 4,000 or more IU per day.2
It is time for clinicians and patients to curb our enthusiasm for vitamin D screening and supplementation. Strategies to decrease unnecessary testing could include distributing the patient handout on vitamin D tests created by Consumer Reports for the Choosing Wisely campaign (http://www.choosingwisely.org/patient-resources/vitamin-d-tests/) and implementing clinical decision support for ordering laboratory tests. In Alberta, Canada, the number of vitamin D tests decreased by more than 90% during the first 12 months after implementation of a paper and electronic requisition form that required physicians who were ordering laboratory tests to select one of several approved indications (e.g., metabolic bone disease, abnormal blood calcium levels, malabsorption syndromes, chronic renal disease, chronic liver disease).16 Family physicians should also counsel patients on the recommended dietary allowance for vitamin D (600 IU per day in adults 70 years and younger, and 800 IU per day in adults older than 70 years), and discourage most patients from using supplements, especially in dosages near or above the tolerable upper limit of 4,000 IU per day.
Editor's Note: Dr. Lin is Associate Deputy Editor of AFP online.
Referencesshow all references
1. Shahangian S, Alspach TD, Astles JR, Yesupriya A, Dettwyler WK. Trends in laboratory test volumes for Medicare Part B reimbursements, 2000–2010. Arch Pathol Lab Med. 2014;138(2):189–203....
2. Rooney MR, Harnack L, Michos ED, Ogilvie RP, Sempos CT, Lutsey PL. Trends in use of high-dose vitamin D supplements exceeding 1000 or 4000 International Units daily, 1999–2014. JAMA. 2017;317(23):2448–2450.
3. LeFevre ML, LeFevre NM. Vitamin D screening and supplementation in community-dwelling adults: common questions and answers. Am Fam Physician. 2018;97(4):254–260.
4. Choosing Wisely. American Society for Clinical Pathology. February 21, 2013. http://www.choosingwisely.org/clinician-lists/american-society-clinical-pathology-population-based-screening-for-vitamin-d-deficiency/. Accessed August 8, 2017.
5. LeFevre ML. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;162(2):133–140.
6. Moyer VA. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(8):558–564.
7. Moyer VA. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9):691–696.
8. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes. BMJ. 2014;348:g2035.
9. Belluz J. Your vitamin D tests and supplements are probably a waste of money. Vox. June 20, 2017. https://www.vox.com/science-and-health/2017/6/20/15838152/vitamin-d-deficiency-foods-symptoms. Accessed August 7, 2017.
10. Scragg R, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial. JAMA Cardiol. 2017;2(6):608–616.
11. Cameron ID, Gillespie LD, Robertson MC, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev. 2012;(12):CD005465.
12. Manson JE, Brannon PM, Rosen CJ, Taylor CL. Vitamin D deficiency – is there really a pandemic? N Engl J Med. 2016;375(19):1817–1820.
13. Jackson RD, LaCroix AZ, Gass M, et al.; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures [published correction appears in N Engl J Med 2006;354(10): 1102]. N Engl J Med. 2006;354(7):669–683.
14. Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176(2):175–183.
15. Ross AC, Taylor CL, Yaktine AL, Del Valle HB; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
16. Naugler C, Hemmelgarn B, Quan H, et al. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open. 2017;5(1):E36–E39.
Copyright © 2018 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Apr 15, 2021
Access the latest issue of American Family Physician